chr3-44862108-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_144638.3(TMEM42):​c.184G>C​(p.Gly62Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000022 in 1,272,668 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

TMEM42
NM_144638.3 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.316
Variant links:
Genes affected
TMEM42 (HGNC:28444): (transmembrane protein 42) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
KIF15 (HGNC:17273): (kinesin family member 15) Predicted to enable microtubule binding activity and microtubule motor activity. Predicted to be involved in microtubule-based movement. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
MIR564 (HGNC:32820): (microRNA 564) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3796765).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM42NM_144638.3 linkc.184G>C p.Gly62Arg missense_variant Exon 1 of 3 ENST00000302392.5 NP_653239.1 Q69YG0
KIF15XR_007095708.1 linkn.4368-6383G>C intron_variant Intron 36 of 36
MIR564NR_030290.1 linkn.*127G>C downstream_gene_variant
MIR564unassigned_transcript_604 n.*187G>C downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM42ENST00000302392.5 linkc.184G>C p.Gly62Arg missense_variant Exon 1 of 3 1 NM_144638.3 ENSP00000306564.4 Q69YG0
TMEM42ENST00000477126.1 linkn.205G>C non_coding_transcript_exon_variant Exon 1 of 2 1
KIF15ENST00000422209.1 linkn.*59+9314G>C intron_variant Intron 6 of 6 3 ENSP00000391205.1 H7BZT2
MIR564ENST00000385049.1 linkn.*127G>C downstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.00000663
AC:
1
AN:
150846
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000660
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000241
AC:
27
AN:
1121822
Hom.:
0
Cov.:
31
AF XY:
0.0000262
AC XY:
14
AN XY:
535248
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24202
American (AMR)
AF:
0.0000893
AC:
1
AN:
11196
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14732
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28532
South Asian (SAS)
AF:
0.00
AC:
0
AN:
27002
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
27816
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3330
European-Non Finnish (NFE)
AF:
0.0000266
AC:
25
AN:
940202
Other (OTH)
AF:
0.0000223
AC:
1
AN:
44810
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000663
AC:
1
AN:
150846
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
73644
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
41242
American (AMR)
AF:
0.0000660
AC:
1
AN:
15160
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3458
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10076
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67600
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 20, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.184G>C (p.G62R) alteration is located in exon 1 (coding exon 1) of the TMEM42 gene. This alteration results from a G to C substitution at nucleotide position 184, causing the glycine (G) at amino acid position 62 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.045
T
Eigen
Benign
-0.028
Eigen_PC
Benign
-0.11
FATHMM_MKL
Benign
0.34
N
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.38
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.22
Sift
Benign
0.067
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.99
D
Vest4
0.28
MutPred
0.73
Gain of methylation at G62 (P = 0.025);
MVP
0.014
MPC
0.76
ClinPred
0.96
D
GERP RS
0.74
PromoterAI
0.012
Neutral
Varity_R
0.11
gMVP
0.42
Mutation Taster
=42/58
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1699261315; hg19: chr3-44903600; API